Showing results (1-10 of 1,072) with videos related to

Sort By:
Pageof 108
International Journal of Molecular Sciences|September 23, 2022
Amyloid-β: Structure, Function, and Pathophysiological Significance in Neurodegenerative DiseasesSatoshi Saito, Kenjiro Ono, Masashi Tanaka
International Journal of Molecular Sciences|March 19, 2020
Potential Therapeutic Approaches for Cerebral Amyloid Angiopathy and Alzheimer's DiseaseMasashi Tanaka, Satoshi Saito, Takayuki Inoue, et al.
International Journal of Molecular Sciences|May 5, 2019
Novel Therapeutic Potentials of Taxifolin for Amyloid-β-associated Neurodegenerative Diseases and Other Diseases: Recent Advances and Future PerspectivesMasashi Tanaka, Satoshi Saito, Takayuki Inoue, et al.
Frontiers in Pharmacology|March 1, 2021
Taxifolin: A Potential Therapeutic Agent for Cerebral Amyloid AngiopathySatoshi Saito, Masashi Tanaka, Noriko Satoh-Asahara, et al.
Neurochemical Research|August 23, 2017
The Oligomer Hypothesis in α-SynucleinopathyKenjiro Ono
Neurochemistry International|August 20, 2017
Alzheimer's disease as oligomeropathyKenjiro Ono
Brain and Nerve = Shinkei Kenkyu No Shinpo|February 10, 2020
[α-Synuclein as Diagnostic Biomarker]Kenjiro Ono
Geriatrics & Gerontology International|January 7, 2012
Vitamin A and Alzheimer's diseaseKenjiro Ono, Masahito Yamada
Brain and Nerve = Shinkei Kenkyu No Shinpo|October 7, 2024
[Anti-Amyloid Antibody Therapy for Alzheimer's Disease]Moeko Shinohara, Kenjiro Ono
Journal of Neurochemistry|January 20, 2011
Low-n oligomers as therapeutic targets of Alzheimer's diseaseKenjiro Ono, Masahito Yamada
Pageof 108